ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0780

High Adolescent Health Needs and Relationship to Disease in Patients with Childhood-Onset Systemic Lupus Erythematosus

Chelsea DeCoste1, Paris Moaf1, Lawrence Ng1, Dragana Ostojic-Aitkens1, Fatima Faruq2, Byran Maguire3, Deborah Levy1, Linda Hiraki1, Alene Toulany1 and Andrea Knight4, 1The Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Research Institute, The Hospital for Sick Children, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada

Meeting: ACR Convergence 2021

Keywords: Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE), with typical onset in adolescence, is a chronic life-threatening disease. In addition to dealing with cSLE, these adolescents endure the unique psychosocial and physical health challenges of this life stage. We aimed to characterize the burden of adolescent health issues faced by patients with cSLE, as well as demographic and disease characteristics associated with adverse adolescent health.

Methods: We conducted a retrospective cohort study of adolescents age 12-18 years with cSLE (meeting ACR and SLICC classification criteria) who were seen by Adolescent Medicine (AM) specialists in the Lupus Clinic at SickKids Hospital, between July 2018-July 2020. As part of our cSLE care model, patients presenting with adolescent health issues were routinely seen by AM in the clinic. Adolescent health issues were characterized using the HEADDSS framework (Home, Education/employment, peer group Activities, Drugs, Sexuality, and Suicide/depression), which was standardly recorded for all AM visits. Issues were classified as presenting and/or identified problems at each visit. Adolescent health burden was tabulated as the number of individual adolescent issues identified per patient. Multiple Poisson regression was used to examine associated patient factors, including age, gender, material deprivation score (measure of social marginalization that accounts for income, housing quality, educational attainment, and family structure), SLE disease activity and damage indices, and high-dose glucocorticoid exposure ( >3 months and any-time dose of >30mg prednisone equivalent).

Results: 226 adolescents with cSLE were seen in the Lupus Clinic during the observation period, of which 106 (47%) were seen by AM. Of these, 88 (83%) were female. Median age at first visit was 14 years (IQR 13, 16). Additional patient characteristics are shown in Table 1. Patients had a median of 2 (1, 3) visits with AM over the study period. Figure 1 shows the range of adolescent health issues described across all visits, of which mood was identified as the top adolescent issue (presenting problem in 22%, and identified issue in 51% of patients). Patients had an average adolescent health burden of 2.8 ± 2.31, defined as the number of separate adolescent health issues identified over the study period. In multiple regression analyses, higher adolescent issue burden was associated with higher glucocorticoid exposure (RR=1.72, 95% CI 1.32-2.24), presence of damage (RR=1.30, 95% CI 1.30, 95% CI 0.99-1.70), higher material deprivation (RR=1.16, CI 1.03-1.29), and lower disease activity (RR=0.96, 95% CI 0.92-0.99). The most common service provided by AM was psychoeducation at 54% (Table 2).

Conclusion: Adolescents with cSLE experience a wide range of physical, emotional, and social issues in addition to their underlying disease. We found that increased cSLE disease severity and social marginalization put teens at higher risk of worse adolescent health issues. This highlights the need to discuss adolescent health during rheumatology clinic visits, and the importance of integrating AM specialists into routine cSLE care.

Table 1. Demographics & Disease Characteristics of Patients with cSLE in Adolescent Medicine Care (n=106)

Table 2. Adolescent Medicine Visit Outcomes and Services Provided for cSLE Patients (N=106)

Figure 1. Adolescent Health Issues in cSLE Patients Across Adolescent Medicine Visits (N=106)


Disclosures: C. DeCoste, None; P. Moaf, None; L. Ng, None; D. Ostojic-Aitkens, None; F. Faruq, None; B. Maguire, None; D. Levy, amgen, 6, sobi, 1, roche, 1, janssen, 1, medexus, 6; L. Hiraki, Novartis, 6; A. Toulany, None; A. Knight, None.

To cite this abstract in AMA style:

DeCoste C, Moaf P, Ng L, Ostojic-Aitkens D, Faruq F, Maguire B, Levy D, Hiraki L, Toulany A, Knight A. High Adolescent Health Needs and Relationship to Disease in Patients with Childhood-Onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/high-adolescent-health-needs-and-relationship-to-disease-in-patients-with-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-adolescent-health-needs-and-relationship-to-disease-in-patients-with-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology